This drugmaker is developing breakthroughs like an ‘EpiPen for heart attacks.’ The market has yet to give it credit
RSS SUMMARY · AGGREGATED FROM CNBC
The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks."
The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks."
The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks."
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Sen. Bill Cassidy signs onto brief calling ‘anti-weaponization’ fund a ‘dire threat’
CNBC·52m ago·3 min read
US
Quantinuum stock opens at $68 per share after IPO
CNBC·1h ago·3 min read
Business
Long-term unemployment is surging in the U.S. There are hidden costs for workers and the economy
CNBC·3h ago·3 min read
US
Former Trump advisor John Bolton agrees to plead guilty to retaining classified information, MS NOW reports
CNBC·4h ago·3 min read
Related
On this beat
Health
Bernard Roizman, Virologist Who Demystified Herpes, Dies at 96
TNYT·4h ago·3 min read
Health
Watermelon Electrolyte Gummies Recipe
WELNESS MAMA·8h ago·3 min read
Health
Can You Treat Dual Diagnosis Online? What The Research Says
AOHL·9h ago·3 min read
Health
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
CNBC·13h ago·3 min read